245 related articles for article (PubMed ID: 36604531)
1. Thermal immuno-nanomedicine in cancer.
Yang Z; Gao D; Zhao J; Yang G; Guo M; Wang Y; Ren X; Kim JS; Jin L; Tian Z; Zhang X
Nat Rev Clin Oncol; 2023 Feb; 20(2):116-134. PubMed ID: 36604531
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanomedicines for synergistic photodynamic immunotherapy based on tumor immune microenvironment.
Guo R; Liu Y; Xu N; Ling G; Zhang P
Eur J Pharm Biopharm; 2022 Apr; 173():103-120. PubMed ID: 35283303
[TBL] [Abstract][Full Text] [Related]
5. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
Martin JD; Cabral H; Stylianopoulos T; Jain RK
Nat Rev Clin Oncol; 2020 Apr; 17(4):251-266. PubMed ID: 32034288
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.
Wang J; Zhou M; Chen F; Liu X; Gao J; Wang W; Wang H; Yu H
J Biomed Nanotechnol; 2021 Aug; 17(8):1486-1509. PubMed ID: 34544528
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles: Properties and Applications in Cancer Immunotherapy.
Iscaro A; Howard NF; Muthana M
Curr Pharm Des; 2019; 25(17):1962-1979. PubMed ID: 31566122
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.
Yang Y; Zhao T; Chen Q; Li Y; Xiao Z; Xiang Y; Wang B; Qiu Y; Tu S; Jiang Y; Nan Y; Huang Q; Ai K
Adv Sci (Weinh); 2022 Oct; 9(28):e2202797. PubMed ID: 35869032
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies.
Zafar A; Hasan M; Tariq T; Dai Z
Bioconjug Chem; 2022 Jun; 33(6):1011-1034. PubMed ID: 34793138
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.
Peng S; Xiao F; Chen M; Gao H
Adv Sci (Weinh); 2022 Jan; 9(1):e2103836. PubMed ID: 34796689
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation.
Li H; Luo Q; Zhang H; Ma X; Gu Z; Gong Q; Luo K
Chem Soc Rev; 2023 Jan; 52(1):47-96. PubMed ID: 36427082
[TBL] [Abstract][Full Text] [Related]
13. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunotherapies revisited: state of the art of conventional treatments and next-generation nanomedicines.
García-Fernández C; Saz A; Fornaguera C; Borrós S
Cancer Gene Ther; 2021 Sep; 28(9):935-946. PubMed ID: 33837365
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
17. Role of intravital imaging in nanomedicine-assisted anti-cancer therapy.
Lu L; Sun Y; Wan C; Hu Y; Lo PC; Lovell JF; Yang K; Jin H
Curr Opin Biotechnol; 2021 Jun; 69():153-161. PubMed ID: 33476937
[TBL] [Abstract][Full Text] [Related]
18. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
19. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
Finn OJ
Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
[TBL] [Abstract][Full Text] [Related]
20. Molecular and nanoengineering approaches towards activatable cancer immunotherapy.
Zhang C; Pu K
Chem Soc Rev; 2020 Jul; 49(13):4234-4253. PubMed ID: 32452475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]